About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Rosuvastatin + Ezetimibe
- Company
- Bahria University
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 2 recruiting
Efficacy results: Not yet reported
2 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 21, 2026
Find a Clinical Trial Near Me
See recruiting studies for Rosuvastatin + Ezetimibe and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT06231966
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
Not yet reported Yonsei University 2462 participants Est. completion 2029-05-06 1 siteOther conditions: Peripheral Artery Disease, Polyvascular DiseaseView official trial listing → -
Recruiting NCT NCT07679828
Polypills Approach for Multiple Cardiovascular Risk Factors
Not yet reported China Medical University, China 8252 participants Est. completion 2030-03-01 15 sitesOther conditions: Hypertension, Dyslipidemia, DiabetesView official trial listing → -
Completed NCT NCT00651144
Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)
Not yet reported Organon and Co 40 participants Est. completion 2003-05Other conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT01420549
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
Not yet reported Ache Laboratorios Farmaceuticos S.A. 129 participants Est. completion 2014-11 7 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT02029625
Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
Not yet reported NVP Healthcare 41 participants Est. completion 2014-03 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02127320
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
Not yet reported Hanmi Pharmaceutical Company Limited 24 participants Est. completion 2014-11 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02251847
The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
Not yet reported IlDong Pharmaceutical Co Ltd 400 participants 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02289430
to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
Not yet reported NVP Healthcare 59 participants Est. completion 2015-02Other conditions: HealthyView official trial listing → -
Completed NCT NCT02445352
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
Not yet reported Alvogen Korea 379 participants Est. completion 2015-03 1 siteOther conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT02730689
A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
Not yet reported Alvogen Korea 66 participants Est. completion 2015-01Other conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02772640
Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
Not yet reported Collegium Medicum w Bydgoszczy 83 participants Est. completion 2020-05 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03217409
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
Not yet reported Yuhan Corporation 85 participants Est. completion 2019-05-23 4 sitesOther conditions: Diabetes Mellitus and HypercholesterolemiaView official trial listing → -
Completed NCT NCT03288038
The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 382 participants Est. completion 2015-11-19 20 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03403556
High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
Not yet reported Yuhan Corporation 140 participants Est. completion 2021-12 6 sitesCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT03434613
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
Not yet reported Yonsei University 64 participants Est. completion 2019-09-11 1 siteMASLD Other conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03446261
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Not yet reported Yuhan Corporation 140 participants Est. completion 2019-03-05 2 sitesType 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03494270
High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
Not yet reported Yuhan Corporation 270 participants Est. completion 2019-09-26 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03532854
Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802
Not yet reported LG Chem 42 participants Est. completion 2019-01-30 1 siteOther conditions: Healthy Male VolunteersView official trial listing → -
Completed NCT NCT03571087
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
Not yet reported Hanlim Pharm. Co., Ltd. 374 participants Est. completion 2015-09Other conditions: Primary HypercholesterolemiaView official trial listing → -
Completed NCT NCT03597412
Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
Not yet reported Yuhan Corporation 236 participants Est. completion 2020-08-12 1 siteCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT03847506
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03872232
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Not yet reported Addpharma Inc. 180 participants Est. completion 2020-08-12 1 siteOther conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Status unknown NCT NCT03947866
Ezetimibe-Rosuvastatin Evaluation Study
Elpen Pharmaceutical Co. Inc. 600 participants Est. completion 2023-09-30 1 siteOther conditions: Hypercholesterolemia, Hyperlipidemias, Combinations of Drugs; DependenceView official trial listing → -
Completed NCT NCT03993236
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Not yet reported Keun-Sik Hong 584 participants Est. completion 2021-09-27 12 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT04056169
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
Not yet reported Yuhan Corporation 50 participants Est. completion 2019-07-23 2 sitesOther conditions: Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With InflammationView official trial listing → -
Completed NCT NCT04074551
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04158076
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 siteOther conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Status unknown NCT NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 siteOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT04322266
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
Not yet reported Hanmi Pharmaceutical Company Limited 61 participants Est. completion 2019-02-13 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04433533
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
Not yet reported Yonsei University 200 participants Est. completion 2023-12 1 siteOther conditions: Left Ventricular Diastolic Dysfunction, HyperlipidemiasView official trial listing → -
Completed NCT NCT04626973
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04659070
To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hanlim Pharm. Co., Ltd. 156 participants Est. completion 2022-05-19 1 siteOther conditions: Primary Hypercholesterolemia, HypertensionView official trial listing → -
Completed NCT NCT04669041
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy
Not yet reported Sanofi 305 participants Est. completion 2022-06-15 40 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT04700436
Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
Not yet reported Seoul National University Hospital 146 participants Est. completion 2024-02-13 26 sitesType 2 diabetes Other conditions: Endocrine System Diseases, Nutritional and Metabolic Diseases, DyslipidemiasView official trial listing → -
Completed NCT NCT04826354
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
Not yet reported Korea University Anam Hospital 582 participants Est. completion 2023-06-28 2 sitesOther conditions: Atheroscleroses, CoronaryView official trial listing → -
Completed NCT NCT04829149
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT04862962
Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia
Laboratorios Silanes S.A. de C.V. 120 participants Est. completion 2022-02-15 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT04895059
Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components
Not yet reported Laboratorios Silanes S.A. de C.V. 36 participants Est. completion 2018-01-22 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT05661552
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
Not yet reported Yonsei University 108 participants Est. completion 2025-02-05 1 site Stand-aloneOther conditions: Low-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaView official trial listing → -
Status unknown NCT NCT05884502
A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke
Not yet reported Korea University Anam Hospital 330 participants Est. completion 2024-12-31 3 sitesCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Active, not recruiting NCT NCT05889143
A Study to Evaluate the Efficacy and Safety of CREZET Tablet
Daewoong Pharmaceutical Co. LTD. 15000 participants Est. completion 2026-03-01 1 siteOther conditions: DyslipidemiasView official trial listing → -
Active, not recruiting NCT NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
Not yet reported Yonsei University 200 participants Est. completion 2026-09-22 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Active, not recruiting NCT NCT06317051
Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Not yet reported Kirby Institute 300 participants Est. completion 2027-12 10 sitesOther conditions: HIV Infections, Weight GainView official trial listing → -
Status unknown NCT NCT06578676
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
Not yet reported Hyundai Pharm 56 participants Est. completion 2024-11-30 1 siteType 2 diabetes Other conditions: DyslipidemiasView official trial listing → -
Enrolling by invitation NCT NCT06646354
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 siteOther conditions: Hypertension, Primary HypercholesterolaemiaView official trial listing → -
Completed NCT NCT06742853
A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.
Not yet reported AstraZeneca 81 participants Est. completion 2025-10-29 3 sitesOther conditions: DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT06767345
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Not yet reported Korea University Anam Hospital 408 participants Est. completion 2028-06-25 7 sitesCardiovascular disease Other conditions: Atherosclerosis of Coronary Artery, Plaque, AtheroscleroticView official trial listing → -
Completed NCT NCT07255820
Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol
Not yet reported Bahria University 126 participants Est. completion 2026-06-30 1 siteType 2 diabetes Other conditions: Hypercholesterolemia / Elevated LDL CholesterolView official trial listing → -
Completed NCT NCT07564726
Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
Not yet reported Celltrion Pharm, Inc. 163 participants Est. completion 2024-02-13 21 sitesOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07674524
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
Sun Yat-sen University 160 participants Est. completion 2029-12-31 1 siteOther conditions: Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positiveView official trial listing → -
Not yet recruiting NCT NCT07871604
Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis
Not yet reported Yonsei University 300 participants Est. completion 2029-09-21 2 sitesCardiovascular diseaseView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.